多囊肾病中的增强子与超级增强子图谱
研究显示小鼠和人类常染色体显性多囊肾病样本中活性增强子标志H3K27ac升高;在Pkd1突变小鼠肾脏中定位超过16000个活性内含子和基因间增强子元件,发现囊性肾脏表观遗传图谱类似发育中肾脏,并鉴定c-Myc下游保守增强子簇及Jun、Fos旁超级增强子,删除这些元件可抑制增殖和三维囊肿生长。
要点
- 常染色体显性多囊肾病小鼠和人类样本中H3K27ac升高。
- Pkd1突变小鼠肾脏中定位超过16000个活性增强子元件。
- 删除c-Myc增强子或Jun、Fos超级增强子可抑制囊肿生长。
核心结论
- 表观遗传重编程介导多囊肾病转录失调,调控元件可被靶向以减缓囊肿生长。
研究设计与样本
- 研究采用小鼠和人类常染色体显性多囊肾病样本进行H3K27ac ChIP-Seq比较分析,并在Pkd1突变细胞中进行调控元件删除实验。
主要发现
- H3K27ac在常染色体显性多囊肾病小鼠和人类样本中升高。
- 在Pkd1突变小鼠肾脏中定位超过16000个活性内含子和基因间增强子元件。
- 囊性肾脏表观遗传图谱类似发育中肾脏,Pkd1突变肾脏中超过90%上调基因与同一拓扑关联结构域内激活增强子共存。
- 在小鼠和人类常染色体显性多囊肾病模型中鉴定c-Myc基因下游进化保守增强子簇及Jun和Fos位点旁超级增强子。
- 删除这些调控元件降低c-Myc、Jun或Fos丰度并抑制Pkd1突变细胞增殖和三维囊肿生长。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Widespread aberrant gene expression is a pathological hallmark of polycystic kidney disease (PKD). Numerous pathogenic signaling cascades, including c-Myc, Fos, and Jun, are transactivated. However, the underlying epigenetic regulators are poorly defined. Here we show that H3K27ac, an acetylated modification of DNA packing protein histone H3 that marks active enhancers, is elevated in mouse and human samples of autosomal dominant PKD. Using comparative H3K27ac ChIP-Seq analysis, we mapped over 16000 active intronic and intergenic enhancer elements in Pkd1-mutant mouse kidneys. We found that the cystic kidney epigenetic landscape resembles that of a developing kidney, and over 90% of upregulated genes in Pkd1-mutant kidneys are co-housed with activated enhancers in the same topologically associated domains. Furthermore, we identified an evolutionarily conserved enhancer cluster downstream of the c-Myc gene and super-enhancers flanking both Jun and Fos loci in mouse and human models of autosomal dominant PKD. Deleting these regulatory elements reduced c-Myc, Jun, or Fos abundance and suppressed proliferation and 3D cyst growth of Pkd1-mutant cells. Finally, inhibiting glycolysis and glutaminolysis or activating Ppara in Pkd1-mutant cells lowerd global H3K27ac levels and its abundance on c-Myc enhancers. Thus, our work suggests that epigenetic rewiring mediates the transcriptomic dysregulation in PKD, and the regulatory elements can be targeted to slow cyst growth.
引用
- Lakhia R, Mishra A, Biggers L, et al. Enhancer and super-enhancer landscape in polycystic kidney disease. Kidney Int. 2022. PMID: 36283570. doi:10.1016/j.kint.2022.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。